Serial Number | 97564810 |
Word Mark | ORGANOX |
Filing Date | Thursday, August 25, 2022 |
Status | 730 - FIRST EXTENSION - GRANTED |
Status Date | Tuesday, July 16, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, December 5, 2023 |
Goods and Services | Medical and veterinary preparations, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; medical and veterinary preparations for use with organs ex vivo, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; perfusion solutions for transplant organs, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; perfusion solutions for organs in vivo and ex vivo, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; therapeutic preparations for organs, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; medical and veterinary preparations for the perfusion of organs, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; nutrition for organs ex vivo, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs, namely, perfusion fluids containing minerals, salts, vitamins, amino acids, proteins, enzymes and other beneficial formulations for organs in vivo and ex vivo; pharmaceuticals for treating organs in vivo or ex vivo, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in for maintaining and improving the quality of organs in vivo or ex vivo; biological preparations for the maintenance of organs inside or outside human or animal bodies, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs |
Goods and Services | Medical and veterinary apparatus and instruments, namely, system for use in artificial organ support; medical and veterinary apparatus and instruments for preserving organs and body parts, namely, systems for use in artificial organ support and in preserving the viability of organs for use in transplantation; medical and veterinary apparatus for perfusing organs inside or outside human or animal bodies, namely, system for use in artificial organ support; electromagnetic medical diagnostic imaging apparatus, namely, medical and veterinary apparatus for enabling functional assessment of donor transplant organs during storage and transportation; normothermic apparatus for ex vivo organs, namely, warming device for stabilizing organ temperature for medical purposes; component parts for all the aforesaid goods |
Goods and Services | Scientific research and development in the fields of maintenance, preservation, transportation and storage of organs in vivo and ex vivo; scientific research and development in relation to the perfusion of donor transplant organs; medical research services in relation to maintaining and improving the quality of organs in vivo or ex vivo; medical and pharmacological research services; product quality and safety testing, namely, conducting efficacy and toxicity testing of pharmaceuticals for others; pharmaceutical research services, namely, conducting pharmacological testing on organs and body parts in vivo or ex vivo, being testing of pharmaceuticals; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy relating to the aforesaid services |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, September 14, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, September 14, 2022 |
Primary Code | 010 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, September 14, 2022 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | OrganOx Limited |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | Littlemore, Oxford OX44GA GB |
Party Name | OrganOx Limited |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Littlemore, Oxford OX44GA GB |
Event Date | Event Description |
Wednesday, June 28, 2023 | NON-FINAL ACTION WRITTEN |
Monday, August 29, 2022 | NEW APPLICATION ENTERED |
Wednesday, September 14, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, June 12, 2023 | ASSIGNED TO EXAMINER |
Wednesday, June 28, 2023 | NON-FINAL ACTION E-MAILED |
Wednesday, June 28, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, September 18, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, September 18, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, September 18, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, September 21, 2023 | FINAL REFUSAL WRITTEN |
Thursday, September 21, 2023 | FINAL REFUSAL E-MAILED |
Thursday, September 21, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Friday, October 20, 2023 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Friday, October 20, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, October 20, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, October 27, 2023 | EXAMINERS AMENDMENT -WRITTEN |
Friday, October 27, 2023 | EXAMINERS AMENDMENT E-MAILED |
Friday, October 27, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Friday, October 27, 2023 | EXAMINER'S AMENDMENT ENTERED |
Friday, October 27, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, December 5, 2023 | PUBLISHED FOR OPPOSITION |
Tuesday, December 5, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, January 30, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, July 16, 2024 | SOU TEAS EXTENSION RECEIVED |
Tuesday, July 16, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, July 16, 2024 | SOU EXTENSION 1 FILED |
Tuesday, July 16, 2024 | SOU EXTENSION 1 GRANTED |
Wednesday, November 15, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |